# Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma

> **NCT06880198** · NA · RECRUITING · sponsor: **Fondazione Melanoma Onlus** · enrollment: 20 (estimated)

## Conditions studied

- Melanoma Metastatic
- Locally Advanced Melanoma

## Interventions

- **DIETARY_SUPPLEMENT:** Oral Impact®

## Key facts

- **NCT ID:** NCT06880198
- **Lead sponsor:** Fondazione Melanoma Onlus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06880198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06880198, "Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06880198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*